Skip to content
ppharmaranks
Menu

atripla

Pharmaranks rates Atripla 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Atripla is a combination medicine containing Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate.

Efavirenz and Emtricitabine and Tenofovir Disoproxil Fumarate · by Gilead Sciences Inc

70/100Limited · 1 source

Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass
Lower-cost optionsSave up to 40%
This medication~$42.28/30
Cheapest in class · abiraterone acetate~$25.50/30
See FDA-approved alternatives

Key facts

Active ingredient
Efavirenz and Emtricitabine and Tenofovir Disoproxil Fumarate
Form
Tablet
Strength
Efavirenz 600MG; Emtricitabine 200MG; Tenofovir Disoproxil Fumarate 300MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
Type
Prescription (Rx)
Brand or generic
Brand-name
What the pharmacy pays
~$42.28 for 30 — not your price
FDA application
NDA021937
Availability
Discontinued (per FDA)

Dosage forms

Tablet

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

How is Atripla rated?
pharmaranks gives Atripla a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
How much does Atripla cost?
Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $42.28 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Abiraterone Acetate — about $25.50 on the same basis.
Is there a coupon or discount for Atripla?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Atripla. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Atripla?
Atripla is marketed by Gilead Sciences Inc. You can see Gilead Sciences Inc's full profile, rating, and other products on pharmaranks.
Is Atripla a brand-name or generic drug?
Atripla is a brand-name product with the active ingredient Efavirenz and Emtricitabine and Tenofovir Disoproxil Fumarate.
Is Atripla available over the counter?
No. Atripla is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Atripla come in?
Atripla is currently marketed as tablet, per the FDA's National Drug Code Directory.
Is Atripla FDA-registered?
Atripla is on record with the U.S. FDA under application number NDA021937. You can verify this on its official FDA label.
Has Atripla been recalled by the FDA?
Atripla has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
Is Atripla safe?
There's no single safe-or-not verdict. pharmaranks gives Atripla a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Atripla head-to-head

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.